Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: A pilot study

Sexual Health

Volumn 7, Issue 3, 2010, Pages 253-261

  Novakovic, Daniel ^a   Cheng, Alan T L ^b   Cope, Daron H ^c   Brotherton, Julia M L ^d,e  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c GOSFORD HOSPITAL   (Australia)

^d VICTORIAN CYTOLOGY SERVICE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

genital warts; HPV; juvenile onset recurrent respiratory papillomatosis; lesions; paediatrics

Indexed keywords

3 INDOLEMETHANOL; BEVACIZUMAB; CIDOFOVIR; CYCLOOXYGENASE 2 INHIBITOR; INTERFERON; WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CARBON DIOXIDE LASER; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; JUVENILE ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS; MALE; MEDICAL RECORD REVIEW; MICROLARYNGOSCOPY; MORBIDITY; ONLINE MONITORING; OTORHINOLARYNGOLOGY; PAPILLOMATOSIS; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT INDICATION; VACCINATION;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; INCIDENCE; INFANT; LARYNGOSCOPY; MALE; OTORHINOLARYNGOLOGIC NEOPLASMS; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ADMISSION; PILOT PROJECTS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956015185     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH09142     Document Type: Article

References (38)

1. Buchinsky FJ, Donfack J, Derkay CS, Choi SS, Conley SF, Meyer III CM, et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One 2008; 3: e2263. doi:10.1371/journal.pone.0002263
2. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 2004; 114(Suppl 104): 1-23. doi:10.1097/01.mlg. 000148224.83491.0f (Pubitemid 39535733)
3. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER, RRP Task Force. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2003; 129: 976-982 doi:10.1001/archotol.129.9.976 (Pubitemid 37087659)
4. Lindeberg H, Oster S, Oxlund I, Elbrond O. Laryngeal papillomas: classification and course. Clin Otolaryngol Allied Sci 1986; 11: 423-429 doi:10.1111/j.1365-2273.1986.tb00146.x
5. Johnson K, Derkay C. Palliative aspects of recurrent respiratory papillomatosis. Otolaryngol Clin North Am 2009; 42: 57-70. doi:10.1016/j.otc. 2008.09.007
6. Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope 1992; 102: 9-13. doi:10.1288/00005537- 199201000-00002
7. Wiatrak BJ. Recurrent respiratory papillomatosis. In Graham JM, Scadding GK, Bull PD, editors. Pediatric ENT. Berlin: Springer- Verlag; 2007. pp. 256-265
8. Cheng ATL, Backer CL, Holinger LD, Dunham ME, Mavroudis C, Gonzalez-Crussi F. Histopathologic changes after pericardial patch tracheoplasty. Arch Otolaryngol Head Neck Surg 1997; 123: 1069-1072 (Pubitemid 27491929)
9. Maran A, Amella CA, DiLorenzo TP, Auborn KJ, Taichman LB, Steinberg BM. Human papillomavirus type 11 transcripts are present at low abundance in latently infected respiratory tissues. Virology 1995; 212: 285-294 doi:10.1006/viro.1995.1486
10. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008; 118: 1236-1247 oi:10.1097/MLG.0b013e3181 6a7135
11. Hawkes M, Campisi P, Zafar R, Punthakee X, Dupuis A, Forte V, et al. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatr Infect DisJ 2008; 27: 149-154
12. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 1998; 108: 735-40. oi:10.1097/00005537-1998050 00-00021 (Pubitemid 28213498)
13. Gelinas JF, Manoukian J, Cote A. Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. Int J Pediatr Otorhinolaryngol 2008; 72: 433-452 doi:10.1016/j.ijporl.2007.12.003
14. Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E. Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck 2007; 29: 155-162 doi:10.1002/hed.20491 (Pubitemid 46167783)
15. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001; 111: 57-69. doi:10.1097/00005537-200101000-00011
16. Wu R, Coniglio SJ, Chan A, Symons MH, Steinberg BM. Upregulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas. Mol Med 2007; 13: 1-50. doi:10.2119/2007-00005.Wu (Pubitemid 46944956)
17. Zeitels SM, Lopez-Guerra G, Burns JA, Lutch M, Friedman AM, Hillman RE. Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Ann Otol Rhinol Laryngol 2009; 118(Suppl 201): 1-24.
18. Haleden C, Majmudar B. The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata. J Reprod Med 1986; 318: 804-807
19. Tenti P. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999; 93: 475-479 doi:10.1016/S0029- 7844(98)00459-1 (Pubitemid 29147060)
20. DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, Bonagura VR. Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med 2008; 14: 1-17. doi:10.2119/2008-00060.DeVoti
21. Stern Y, Felipovich A, Cotton RT, Segal K. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study. Ann Otol Rhinol Laryngol 2007; 116: 169-171
22. Shah K, Kashima H, Polk BF, Shah F, Abbey H, Abramson A, et al. Rarity of cesearean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986; 68: 795-799
23. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928-1943 doi:10.1056/NEJMoa061760 (Pubitemid 46740303)
24. Schaffer A, Brotherton J, Booy R. Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children? J Paediatr Child Health 2007; 43: 579-580 doi:10.1111/j.1440-1754. 2007.01205.x (Pubitemid 47222703)
25. Matys K, Hood S, Bautista O, Esser M, Saah A. Maternal transfer of anti-HPV antibodies following vaccination with Gardasil. [conference abstract] P-03.51. Presented at the 25th International Papillomavirus Conference, Malmo, Sweden, 8-14 May, 2009.
26. Somers GR, Tabrizi SN, Borg AJ, Garland SM, Chow CW. Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med 1997; 17: 53-64. doi:10.1080/10771 0497175029 (Pubitemid 27065464)
27. Benjamin B, Parsons DS. Recurrent respiratory papillomatosis: a 10 year study. J Laryngol Otol 1988; 102: 1022-8. doi:10.1017/ S0022215100107169
28. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R, Rose BR. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 1997; 35: 3098-3103
29. Schraff S, Derkay CS, Burke B, Lawson L. American Society of Pediatric Otolaryngology members experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004; 130: 1039-1042 doi:10.1001/ archotol.130.9.1039
30. Australian Institute of Health and Welfare. Interactive national hospital data (datacubes). Available online at: . au/hospitals/datacubes/index.cfm [verified 7 June 2010].
31. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg 2004; 130: 711-716 doi:10.1001/archotol.130.6.711 (Pubitemid 38725044)
32. Australian Institute of Health and Welfare. Indigenous identification in hospital separations data-quality report. Health Services Series no.35. Cat.no. HSE 85. Canberra: AIHW; 2010.
33. Campisi P, Canadian JORRP Working Group. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope 2010; 120: 1233-1245
34. Carvalho CM, Huot L, Charlois A-L, Khalfallah SA, Chapuis F, Froehlich P. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol 2009; 129: 462-470 doi:10.1080/00016480902737986
35. Nunez DA. Update on human papilloma virus vaccination and the European recurrent respiratory papillomatosis registry. Clin Otolaryngol 2009A; 34: 12.
36. He S, Zurynski YA, Elliott EJ. Evaluation of a national resource to identify and study rare diseases: the Australian Paediatric Surveillance Unit. J Paediatr Child Health 2009; 45: 498-504. doi:10.1111/j.1440- 1754.2009.01549.x
37. Mouadeb DA, Belafsky PC. In-office laryngeal surgery with the 585 nm pulsed dye laser (PDL). Otolaryngol Head Neck Surg 2007; 137: 477-481 doi:10.1016/j.otohns.2007.02.003 (Pubitemid 47320852)
38. Rees CJ, Postma GN, Koufman JA. Cost savings of unsedated officebased laser surgery for laryngeal papillomas. Ann Otol Rhinol Laryngol 2007; 116: 45-48